NPI: 1699129403 · SOUTH SAN FRANCISCO, CA 94080 · Community Health Clinic/Center · NPI assigned 04/18/2016
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 04/18/2016 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,844 | $144K |
| 2019 | 5,116 | $205K |
| 2020 | 2,279 | $93K |
| 2021 | 7,026 | $304K |
| 2022 | 5,077 | $261K |
| 2023 | 10,735 | $707K |
| 2024 | 11,884 | $738K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 335 | 314 | $385K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,728 | 3,519 | $327K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,781 | 1,727 | $249K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,575 | 1,565 | $241K |
| J3490 | Unclassified drugs | 4,620 | 3,867 | $175K |
| S4993 | Contraceptive pills for birth control | 1,288 | 1,272 | $150K |
| 87806 | 5,507 | 4,844 | $147K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,986 | 1,908 | $140K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 341 | 338 | $100K |
| 90651 | 323 | 318 | $90K | |
| 11981 | 332 | 311 | $86K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 360 | 355 | $85K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,450 | 1,428 | $46K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,293 | 1,205 | $38K |
| 99201 | 328 | 326 | $36K | |
| 99401 | 1,838 | 1,769 | $35K | |
| A4267 | Contraceptive supply, condom, male, each | 2,377 | 2,317 | $22K |
| 99000 | 3,436 | 3,397 | $13K | |
| 81025 | 3,573 | 3,467 | $11K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 808 | 808 | $10K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 2,216 | 2,122 | $9K |
| S5000 | Prescription drug, generic | 1,233 | 1,130 | $9K |
| 83986 | 2,882 | 2,518 | $9K | |
| 58300 | 86 | 43 | $9K | |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 13 | 13 | $8K |
| 99402 | 157 | 156 | $5K | |
| 11976 | 72 | 37 | $5K | |
| S0190 | Mifepristone, oral, 200 mg | 38 | 38 | $3K |
| 58301 | 60 | 30 | $2K | |
| 99070 | 734 | 524 | $2K | |
| 81002 | 905 | 861 | $2K | |
| 99403 | 31 | 30 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 182 | 179 | $802.72 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 19 | 18 | $561.06 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15 | 14 | $403.91 |
| S0191 | Misoprostol, oral, 200 mcg | 39 | 39 | $128.52 |